MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Effectiveness of case management interventions in reducing common preventable complications associated with Parkinson’s Disease: A Systematic Review and Meta-analysis

    A. van Halteren, J. Janssen Daalen, J. Ypinga, B. Bloem, M. Meinders, M. Munneke, S. Darweesh (Nijmegen, Netherlands)

    Objective: We sought to systematically examine the effectiveness of case management interventions on common preventable complications associated with Parkinson’s Disease, both in people with Parkinson’s…
  • MDS Virtual Congress 2020

    Multimodal model of Parkinson’s disease highlights differences in progression profiles of RBD patients

    R. Couronné, A. Valladier, M. Vidailhet, J.C Corvol, S. Lehericy, S. Durrleman (Paris, France)

    Objective: To compare subgroups of patients with Parkinson’s disease (PD) with and without rapid eye movement sleep behavior disorders (RBD), in terms of progression speed,…
  • MDS Virtual Congress 2020

    White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

    T. Belal, S. Elgamal (Mansoura, Egypt)

    Objective: Studying white matter changes in Parkinson's disease patients using diffusion tensor imaging; and its relation to cognition and motor symptoms impairment. Background: Cognitive dysfunction…
  • MDS Virtual Congress 2020

    Regional cortical thickness alterations in PD patients with cognitive impairment

    V. Goyal, S. Chaudhary, A. Ankeeta, S. Kumaran, P. Bhat (New Delhi, India)

    Objective: To evaluate the cortical thickness alterations in cognitively impaired patients with PD (PD-CI) in a comparative study with cognitively normal patients with PD (PD-CN)…
  • MDS Virtual Congress 2020

    Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease

    K. Longardner, E. Bayram, I. Litvan (San Diego, CA, USA)

    Objective: To compare cognitive changes over time between Parkinson's disease (PD) patients with orthostatic hypotension (OH) and without OH, and between those with symptomatic OH…
  • MDS Virtual Congress 2020

    The feasibility of cognitive telerehabilitation in patients with Parkinson´s disease: The pilot data

    V. Plzáková (Prague, Czech Republic)

    Objective: The aim of this study was to focus on the feasibility and potential benefits of cognitive telerehabilitation (CTR) in patients with Parkinson´s disease (PD).…
  • MDS Virtual Congress 2020

    The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease

    T. Utsunomiya, K. Matsuura, Y. Ii, A. shindo, m. Umino, M. Maeda, H. Tomimoto (Tsu Mie, Japan)

    Objective: We investigate the relationship  between the contrast ratio of locus coeruleus (LC-CR) in neuromelanin-sensitive MRI(NMI), MIBG scintigraphy, and cognition/hallucination, in patients with Parkinson’s disease.…
  • MDS Virtual Congress 2020

    An introduction to the Global Parkinson’s Genetics Program (GP2)

    C. Blauwendraat, E. Riley, A. Singleton (Bethesda, MD, USA)

    Objective: Expanding the current understanding of the genetic architecture of Parkinson’s disease (PD), accelerate discovery and validation of novel disease-causing genetic mutations and provide training…
  • MDS Virtual Congress 2020

    Apolipoprotein E ε4 and risk of freezing of gait in early Parkinson’s disease

    R. Kim, J.S Jun, H.J Kim, B.S Jeon (Incheon, Republic of Korea)

    Objective: To investigate the association between Apolipoprotein E (APOE) genotype and freezing of gait (FOG) in Parkinson’s disease (PD). Background: This cohort study using the…
  • MDS Virtual Congress 2020

    A novel likely pathogenic SNCA variant associated with Parkinson’s disease

    B. Minafra, G. Buongarzone, S. Gana, M.L Valente, I. Palmieri, T. Biagini, M. Plumari, M. Avenali, R. Zangaglia, T. Mazza, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report a novel SNCA likely pathogenic variant. Background: The A53T mutation in the SNCA gene, encoding alpha-synuclein (a-syn), was the first established genetic…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley